Viral Disease Diagnosis Market Forecast and CAGR
According to the latest research by Fact MR, Viral Disease Diagnosis Market is set to experience 8% growth during the year 2021-2031. According to the research, Viral Disease Diagnosis consist of estimating a load of either antigen or antigen-specific antibodies due to immune response. The growth of diagnostics is anticipated due to the rise in viral infections and diseases. According to WHO, the fatality rate due to Ebola virus disease is around 50% and annually 3-5 million cases of severe illness is caused due to influenza virus.
What is Driving Demand for Viral Disease Diagnosis?
Changes in the viral genome act as the primary challenge for the detection of the virus . Due to which the diagnosis becomes difficult. Hence, various new techniques like microarray techniques and rapid tests are emerging. The global virological diagnosis is expected to be driven by increased research and development for the detection of the virus. According to WHO, globally 1.5 million new infections occur per year. This upsurge in infection rates will directly have a positive impact on the viral diagnostic market.
The rising prevalence of COVID, which is caused by SARS-CoV 2 virus is anticipated to drive market growth over the forecast period. This accelerates the demand for diagnostic kits for the detection of viral disease. Apart from this, the demand for the rapid test which gives precise and accurate in a short period is also increasing. This acts as the driver for the market.
Get a sample of this report: https://www.factmr.com/connectus/sample?flag=S&rep_id=6920
Who are the Key Manufacturers and Suppliers of Veterinary Home Diagnostics?
Some of the key players operating in the Viral Disease Diagnosis Market are
- Thermo Fisher Scientific
- Adaltis S.r.l
- R-Biopharm AG
- Siemens Healthcare Private Limited
- Toronto Bioscience
- Merck KGaA
- Abbott Laboratories
- BioMérieux SA
- Cepheid
- Epitope Diagnostics Inc.
- F. Hoffmann-La Roche Ltd
- Elabscience Biotechnology Inc.
- Mylab Discovery Solutions Pvt. Ltd.
- Altona Diagnostics GmbH
- TIB Molbiol
- Luminex Corporation
- Becton
- Dickinson and Company.
Request for customization of the report: https://www.factmr.com/connectus/sample?flag=RC&rep_id=6920
Key Segment
-
By Product Type
- Direct specimen examination
- Viral isolation
- Molecular techniques
- Microarray technique
- Serodiagnostic kits
-
By End-Use
- Homecare
- Diagnostic Centres
- Nursing homes
- Hospitals
- Clinics
- Laboratories
-
By Virus
- HIV infection
- SARS-CoV
- Influenza viruses.
- hepatitis C virus
- hepatitis B virus
- hepatitis A virus
- Influenza A and Influenza B viruses
-
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- The Middle East and Africa
Purchase a copy of this report: https://www.factmr.com/checkout/6920
About Fact.MR
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Website: https://www.factmr.com